Penumbra agreed to be acquired by rival Boston Scientific for $374 a share, the companies announced Thursday.
Read More from Bizjournals.com Feed (2025-02-17 17:26:56)
One of Alameda’s largest companies agrees to be acquired for $14.5 billion
Friday, January 16